Enabling low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of essential medicines and related pharmaceutical services.
Improving pharmaceutical services, including product availability and patient-centered care, to achieve health outcomes
Increasing the availability and use of pharmaceutical information for decision making and advancing the global learning agenda
Increasing institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products
By Jane Briggs, Senior Principal Technical Advisor and MNCH Lead, MTaPS
View More Stories
By Jane Briggs, Senior Principal Technical Advisor and MNCH Lead, MTaPS
A significant proportion of maternal and child deaths can be avoided if women and children have access to quality, adequate health services and if the necessary quality medical products, supplies, and skilled health providers are available.
Antibiotics are essential for both human and animal health. The symbiotic relationship among humans, animals, and the environment requires a multisectoral, transdisciplinary approach to control the growing crisis of antimicrobial resistance (AMR)—an approach that is enshrined in One Health.
